FREEPORT, N.Y., Sept. 26 Physicians nationwide reportpromising results in treating facial bruising from injectable cosmetictreatments by using Pinoxide(TM), an active ingredient best known for treatingunder-eye circles.
Pinoxide is a proprietary blend of bicyclic monoterpene dials (BMTd)created by AGI Dermatics and formulated in the company's RemergentMicrocirculation Therapy product. Pinoxide has been clinically proven to speedblood flow, warm the skin, increase resistance to cold, and reduce dark under-eye symptoms. Additional research suggests Pinoxide may also contribute topromoting firmness and resiliency in the skin. Now, physicians are studyingthe ingredient's ability to heal bruising.
Dr. Mark G. Rubin, a board-certified dermatologist currently practicing atthe Lasky Clinic in Beverly Hills, is conducting the clinical trials onPinoxide, applying the Microcirculation Therapy formula to the injection siteimmediately after use of skin fillers such as collagen, Restylane andJuvederm, or Botox.
"Anatomically speaking, dark circles are like bruises - so the sciencebehind using Pinoxide for bruising makes total sense," said Dr. Rubin. "Theskin discoloration during bruising is the result of blood leaking from damagedblood vessels and surfacing to the skin. Similarly, blood vessels under theeyes can burst, leading to the appearance of unattractive dark circles."
Leading dermatologists share Dr. Rubin's opinion. Dr. Thomas Francel, aboard certified plastic surgeon, has found that application ofMicroCirculation Therapy on his patients reduces the appearance of skinbruising, and decreases the amount of healing time for the bruise. Dr. Francelis the Chief of Plastic Surgery at St. John's Mercy Medical Center and anAssociate Professor of Surgery at St. Louis University.
Injectable cosmetic treatments are among the five top most requestedaesthetic treatments nationwide last year. According to the American Societyfor Aesthetic Plastic Surgery, more than 5 million women had injectablecosmetic treatments last year. Bruising is a common temporary side effect.
AGI Dermatics is the bio-pharmaceutical laboratory that has led theresearch of DNA repair of the skin for more than 20 years. Founded by DanielB. Yarosh, PhD, AGI Dermatics specializes in skin photobiology, dedicatingresearch and development to DNA repair, solar impact on the immune system, andcell-signaling in skin. The company's application of groundbreaking activeingredients and meticulously engineered liposome delivery systems is validatedin controlled clinical studies and published in dozens of peer-reviewedscientific and medical journals. www.agiderm.com
SOURCE AGI Dermatics